General Information of the Protein
Protein ID
PT04096
Protein Name
Free fatty acid receptor 2
Secondarily
Protein Name
G-protein coupled receptor 43
Gene Name
FFAR2
Secondarily
Gene Name
FFA2
GPCR43
GPR43
Sequence
MLPDWKSSLILMAYIIIFLTGLPANLLALRAFVGRIRQPQPAPVHILLLSLTLADLLLLLLLPFKIIEAASNFRWYLPKVVCALTSFGFYSSIYCSTWLLAGISIERYLGVAFPVQYKLSRRPLYGVIAALVAWVMSFGHCTIVIIVQYLNTTEQVRSGNEITCYENFTDNQLDVVLPVRLELCLVLFFIPMAVTIFCYWRFVWIMLSQPLVGAQRRRRAVGLAVVTLLNFLVCFGPYNVSHLVGYHQRKSPWWRSIAVVFSSLNASLDPLLFYFSSSVVRRAFGRGLQVLRNQGSSLLGRRGKDTAEGTNEDRGVGQGEGMPSSDFTTE
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Membrane receptor
>
Family A G protein-coupled receptor
>
Small molecule receptor (family A GPCR)
>
Lipid-like ligand receptor (family A GPCR)
>
Free fatty acid receptor
Function
G protein-coupled receptor that is activated by a major product of dietary fiber digestion, the short chain fatty acids (SCFAs), and that plays a role in the regulation of whole-body energy homeostasis and in intestinal immunity. In omnivorous mammals, the short chain fatty acids acetate, propionate and butyrate are produced primarily by the gut microbiome that metabolizes dietary fibers. SCFAs serve as a source of energy but also act as signaling molecules. That G protein-coupled receptor is probably coupled to the pertussis toxin-sensitive, G(i/o)-alpha family of G proteins but also to the Gq family (PubMed:12496283, PubMed:12711604, PubMed:23589301). Its activation results in the formation of inositol 1,4,5-trisphosphate, the mobilization of intracellular calcium, the phosphorylation of the MAPK3/ERK1 and MAPK1/ERK2 kinases and the inhibition of intracellular cAMP accumulation. May play a role in glucose homeostasis by regulating the secretion of GLP-1, in response to short-chain fatty acids accumulating in the intestine. May also regulate the production of LEP/Leptin, a hormone acting on the central nervous system to inhibit food intake. Finally, may also regulate whole-body energy homeostasis through adipogenesis regulating both differentiation and lipid storage of adipocytes. In parallel to its role in energy homeostasis, may also mediate the activation of the inflammatory and immune responses by SCFA in the intestine, regulating the rapid production of chemokines and cytokines. May also play a role in the resolution of the inflammatory response and control chemotaxis in neutrophils. In addition to SCFAs, may also be activated by the extracellular lectin FCN1 in a process leading to activation of monocytes and inducing the secretion of interleukin-8/IL-8 in response to the presence of microbes (PubMed:21037097). Among SCFAs, the fatty acids containing less than 6 carbons, the most potent activators are probably acetate, propionate and butyrate (PubMed:12496283, PubMed:12711604). Exhibits a SCFA-independent constitutive G protein-coupled receptor activity (PubMed:23066016).
    Show/Hide
Uniprot ID
Primary ID:
O15552

Secondarily ID:
B0M0J9
Q4VAZ3
Q4VAZ5
Q4VBL5
    Show/Hide
Ensembl ID
ENSG00000126262
HGNC ID
HGNC:4501
Subcellular Location
Cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000011 , CHO
Compound ID Compound Name Compound Formula
CP0078179
3-[4-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methoxy]phenyl]propanoic acid
   Show/Hide
C18H15ClN2O4
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0078180
3-[4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]phenyl]propanoic acid
   Show/Hide
C20H19NO4
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0141574
3-[4-[[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]methoxy]phenyl]propanoic acid
   Show/Hide
C19H18N2O4
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0054882
3-[5-[[3-(4-fluorophenyl)phenyl]carbamoyl]-1,3,4-thiadiazol-2-yl]propanoic acid
   Show/Hide
C18H14FN3O3S
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0065854
3-[5-[[3-(3-methylphenyl)phenyl]carbamoyl]-1,3,4-thiadiazol-2-yl]propanoic acid
   Show/Hide
C19H17N3O3S
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0191122
3-[4-[[5-[(2-fluorophenyl)carbamoyl]-1,3,4-thiadiazol-2-yl]methoxy]phenyl]propanoic acid
   Show/Hide
C19H16FN3O4S
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0452086
3-[4-[[5-[(3,4-difluorophenyl)carbamoyl]-1,3,4-thiadiazol-2-yl]methoxy]phenyl]propanoic acid
   Show/Hide
C19H15F2N3O4S
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0388929
3-[4-[[4-[(4-benzyl-1-oxa-9-azaspiro[5.5]undecan-9-yl)methyl]phenyl]methoxy]phenyl]propanoic acid;hydrochloride
   Show/Hide
C33H40ClNO4
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0400943
3-[4-[[4-[[4-[(4-methoxyphenyl)methyl]-1-oxa-9-azaspiro[5.5]undecan-9-yl]methyl]phenyl]methoxy]phenyl]propanoic acid;hydrochloride
   Show/Hide
C34H42ClNO5
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0455532
3-[4-[[4-[[4-[(4-fluorophenyl)methyl]-1-oxa-9-azaspiro[5.5]undecan-9-yl]methyl]phenyl]methoxy]phenyl]propanoic acid;hydrochloride
   Show/Hide
C33H39ClFNO4
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0456185
3-[4-[[4-[[4-[(4-methylphenyl)methyl]-1-oxa-9-azaspiro[5.5]undecan-9-yl]methyl]phenyl]methoxy]phenyl]propanoic acid;hydrochloride
   Show/Hide
C34H42ClNO4
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0476696
3-[4-[[4-[[4-[2-(6-methylpyridin-2-yl)oxyethyl]-1-oxa-9-azaspiro[5.5]undecan-9-yl]methyl]phenyl]methoxy]phenyl]propanoic acid;dihydrochloride
   Show/Hide
C34H44Cl2N2O5
 1
1
EC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0470898
(S)-2-(4-chlorophenyl)-N-(5-fluorothiazol-2-yl)-3-methylbutanamide
   Show/Hide
C14H14ClFN2OS
 1
1
IC50 = 500 nM
   TI
   LI
   LO
   TS
CP0514315
(S)-2-(4-chlorophenyl)-3,3-dimethyl-N-(5-(methylthio)thiazol-2-yl)butanamide
   Show/Hide
C16H19ClN2OS2
 1
1
IC50 = 500 nM
   TI
   LI
   LO
   TS
CP0452740
(S)-2-(4-chlorophenyl)-4-methyl-N-(thiazol-2-yl)pentanamide
   Show/Hide
C15H17ClN2OS
 1
1
IC50 = 600 nM
   TI
   LI
   LO
   TS
CP0426945
(S)-2-(4-chlorophenyl)-3-methyl-N-(thiazol-2-yl)butanamide
   Show/Hide
C14H15ClN2OS
 1
1
IC50 = 700 nM
   TI
   LI
   LO
   TS
CP0452739
(S)-2-(4-chlorophenyl)-3,3-dimethyl-N-(5-phenylthiazol-2-yl)butanamide
   Show/Hide
C21H21ClN2OS
 1
1
IC50 = 700 nM
   TI
   LI
   LO
   TS
CP0502612
(S)-2-(4-chlorophenyl)-N-(5-fluorothiazol-2-yl)-3,3-dimethylbutanamide
   Show/Hide
C15H16ClFN2OS
 1
1
IC50 = 700 nM
   TI
   LI
   LO
   TS
CP0518887
(S)-2-(4-chlorophenyl)-N-(5-chlorothiazol-2-yl)-3-methylbutanamide
   Show/Hide
C14H14Cl2N2OS
 1
1
IC50 = 700 nM
   TI
   LI
   LO
   TS
CP0518889
(S)-N-(5-bromothiazol-2-yl)-2-(4-chlorophenyl)-3,3-dimethylbutanamide
   Show/Hide
C15H16BrClN2OS
 1
1
IC50 = 700 nM
   TI
   LI
   LO
   TS
CP0447158
2-(4-chlorophenyl)-3-methyl-N-(thiazol-2-yl)butanamide
   Show/Hide
C14H15ClN2OS
 1
1
IC50 = 800 nM
   TI
   LI
   LO
   TS
CP0507703
(S)-2-(4-chlorophenyl)-3-methyl-N-(5-methylthiazol-2-yl)butanamide
   Show/Hide
C15H17ClN2OS
 1
1
IC50 = 800 nM
   TI
   LI
   LO
   TS
CP0518888
(S)-2-(4-chlorophenyl)-N-(5-chlorothiazol-2-yl)-3,3-dimethylbutanamide
   Show/Hide
C15H16Cl2N2OS
 1
1
IC50 = 1000 nM
   TI
   LI
   LO
   TS
CP0383863
(S)-2-cyclopropyl-N-(5-fluorothiazol-2-yl)-2-(4-(trifluoromethyl)phenyl)acetamide
   Show/Hide
C15H12F4N2OS
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0492775
(S)-2-(4-chlorophenyl)-N-(6-fluoropyridin-2-yl)-3-methylbutanamide
   Show/Hide
C16H16ClFN2O
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0514319
(S)-2-(4-chlorophenyl)-N-(thiazol-2-yl)pent-4-enamide
   Show/Hide
C14H13ClN2OS
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0514318
(S)-2-(4-chlorophenyl)-2-cyclopropyl-N-(5-fluorothiazol-2-yl)acetamide
   Show/Hide
C14H12ClFN2OS
 1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0520448
(S)-2-(4-chlorophenyl)-N-(5-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)thiazol-2-yl)-3,3-dimethylbutanamide
   Show/Hide
C18H17ClF6N2O2S
 1
1
IC50 = 1200 nM
   TI
   LI
   LO
   TS
CP0426928
(S)-2-(4-chlorophenyl)-N-(5-fluoropyridin-2-yl)-3-methylbutanamide
   Show/Hide
C16H16ClFN2O
 1
1
IC50 = 1300 nM
   TI
   LI
   LO
   TS
CP0421849
(S)-2-(4-chlorophenyl)-3-methyl-N-(4-methylthiazol-2-yl)butanamide
   Show/Hide
C15H17ClN2OS
 1
1
IC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0491224
(S)-2-(4-chlorophenyl)-3-methyl-N-(pyridin-2-yl)butanamide
   Show/Hide
C16H17ClN2O
 1
1
IC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0373546
1-(4-chlorophenyl)-N-(5-fluorothiazol-2-yl)cyclobutanecarboxamide
   Show/Hide
C14H12ClFN2OS
 1
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0426934
(S)-2-(4-chlorophenyl)-3-methyl-N-(5-(trifluoromethyl)thiazol-2-yl)butanamide
   Show/Hide
C15H14ClF3N2OS
 1
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0513958
(S)-2-(4-chlorophenyl)-3,3-dimethyl-N-(5-(trifluoromethyl)thiazol-2-yl)butanamide
   Show/Hide
C16H16ClF3N2OS
 1
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0517600
(S)-2-(4-chlorophenyl)-N-(5-cyanothiazol-2-yl)-3,3-dimethylbutanamide
   Show/Hide
C16H16ClN3OS
 1
1
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0492779
(S)-2-(4-chlorophenyl)-3,3-dimethyl-N-(5-morpholinothiazol-2-yl)butanamide
   Show/Hide
C19H24ClN3O2S
 1
1
IC50 = 1600 nM
   TI
   LI
   LO
   TS
CP0510721
(S)-2-(4-chlorophenyl)-N-(5-(dimethylamino)thiazol-2-yl)-3,3-dimethylbutanamide
   Show/Hide
C17H22ClN3OS
 1
1
IC50 = 1600 nM
   TI
   LI
   LO
   TS
CP0452738
(S)-2-(4-chlorophenyl)-N-(4,5-dimethylthiazol-2-yl)-3-methylbutanamide
   Show/Hide
C16H19ClN2OS
 1
1
IC50 = 1800 nM
   TI
   LI
   LO
   TS
CP0521387
(S)-2-(4-chlorophenyl)-3-methyl-N-(5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)butanamide
   Show/Hide
C14H13ClF3N3OS
 1
1
IC50 = 1900 nM
   TI
   LI
   LO
   TS
CP0447711
(S)-methyl 2-(2-(4-chlorophenyl)-3-methylbutanamido)thiazole-5-carboxylate
   Show/Hide
C16H17ClN2O3S
 1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0492777
(S)-2-(4-chlorophenyl)-3-methyl-N-(1,2,4-thiadiazol-5-yl)butanamide
   Show/Hide
C13H14ClN3OS
 1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0520445
(S)-2-(4-chlorophenyl)-N-(5-cyanothiazol-2-yl)-3-methylbutanamide
   Show/Hide
C15H14ClN3OS
 1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0502892
(S)-2-(4-chlorophenyl)-N-(4,5-dihydrothiazol-2-yl)-3-methylbutanamide
   Show/Hide
C14H17ClN2OS
 1
1
IC50 = 2100 nM
   TI
   LI
   LO
   TS
CP0402054
(S)-2-(4-chlorophenyl)-3-methyl-N-(pyridazin-3-yl)butanamide
   Show/Hide
C15H16ClN3O
 1
1
IC50 = 2300 nM
   TI
   LI
   LO
   TS
CP0492780
(S)-2-(4-Chloro-phenyl)-N-[5-(1,1-dioxo-1lambda*6*-thiomorpholin-4-yl)-thiazol-2-yl]-3,3-dimethyl-butyramide
   Show/Hide
C19H24ClN3O3S2
 1
1
IC50 = 2400 nM
   TI
   LI
   LO
   TS
CP0498696
N-(1,3-benzothiazol-2-yl)-2-(4-chlorophenyl)-3-methylbutanamide
   Show/Hide
C18H17ClN2OS
 1
1
IC50 = 3000 nM
   TI
   LI
   LO
   TS
CP0502613
(S)-2-(4-chlorophenyl)-3,3-dimethyl-N-(5-(methylsulfonyl)thiazol-2-yl)butanamide
   Show/Hide
C16H19ClN2O3S2
 1
1
IC50 = 3400 nM
   TI
   LI
   LO
   TS
CP0514316
(S)-2-(4-chlorophenyl)-3,3-dimethyl-N-(5-(4-methylpiperazin-1-yl)thiazol-2-yl)butanamide
   Show/Hide
C20H27ClN4OS
 1
1
IC50 = 3800 nM
   TI
   LI
   LO
   TS
CP0452736
(S)-N-(5-chlorobenzo[d]oxazol-2-yl)-2-(4-chlorophenyl)-3-methylbutanamide
   Show/Hide
C18H16Cl2N2O2
 1
1
IC50 = 4300 nM
   TI
   LI
   LO
   TS
CP0447713
(S)-2-(4-chlorophenyl)-N-(thiazol-2-yl)butanamide
   Show/Hide
C13H13ClN2OS
 1
1
IC50 = 5000 nM
   TI
   LI
   LO
   TS
CP0452741
1-(4-chlorophenyl)-N-(5-fluorothiazol-2-yl)cyclopentanecarboxamide
   Show/Hide
C15H14ClFN2OS
 1
1
IC50 = 5000 nM
   TI
   LI
   LO
   TS
CP0426931
N-(1H-benzimidazol-2-yl)-2-(4-chlorophenyl)-3-methylbutanamide
   Show/Hide
C18H18ClN3O
 1
1
IC50 = 5200 nM
   TI
   LI
   LO
   TS
CP0373545
(S)-2-(4-chlorophenyl)-N-(thiazol-2-yl)pentanamide
   Show/Hide
C14H15ClN2OS
 1
1
IC50 = 5500 nM
   TI
   LI
   LO
   TS
CP0507700
2-(4-chlorophenyl)-3-methyl-N-pyrazin-2-ylbutanamide
   Show/Hide
C15H16ClN3O
 1
1
IC50 = 5700 nM
   TI
   LI
   LO
   TS
CP0426932
(S)-N-(4-tert-butylthiazol-2-yl)-2-(4-chlorophenyl)-3-methylbutanamide
   Show/Hide
C18H23ClN2OS
 1
1
IC50 = 7900 nM
   TI
   LI
   LO
   TS
CP0514889
1-(4-chlorophenyl)-N-(5-fluorothiazol-2-yl)cyclohexanecarboxamide
   Show/Hide
C16H16ClFN2OS
 1
1
IC50 = 8500 nM
   TI
   LI
   LO
   TS
CP0491226
(S)-2-(4-chlorophenyl)-3-cyclopropyl-N-(thiazol-2-yl)propanamide
   Show/Hide
C15H15ClN2OS
 1
1
IC50 = 8800 nM
   TI
   LI
   LO
   TS
CP0507699
(S)-2-(4-chlorophenyl)-N,3-dimethylbutanamide
   Show/Hide
C12H16ClNO
 1
1
IC50 = 11000 nM
   TI
   LI
   LO
   TS
CP0426929
(S)-2-(4-chlorophenyl)-3-methyl-N-(1,3,4-thiadiazol-2-yl)butanamide
   Show/Hide
C13H14ClN3OS
 1
1
IC50 = 12000 nM
   TI
   LI
   LO
   TS
CP0421851
(S)-2-(2-chloropyridin-4-yl)-2-cyclopropyl-N-(5-fluorothiazol-2-yl)acetamide
   Show/Hide
C13H11ClFN3OS
 1
1
IC50 = 16000 nM
   TI
   LI
   LO
   TS
CP0452737
(S)-2-(4-chlorophenyl)-3-methyl-N-(4-(trifluoromethyl)thiazol-2-yl)butanamide
   Show/Hide
C15H14ClF3N2OS
 1
1
IC50 = 17000 nM
   TI
   LI
   LO
   TS
CP0518883
(S)-2-(4-chlorophenyl)-N-(1H-imidazol-2-yl)-3-methylbutanamide
   Show/Hide
C14H16ClN3O
 1
1
IC50 = 20000 nM
   TI
   LI
   LO
   TS
CP0902546
(S)-2-(4-chlorophenyl)-3-methyl-N-(4-oxo-4,5-dihydrothiazol-2-yl)butanamide
   Show/Hide
C14H15ClN2O2S
 1
1
IC50 = 20000 nM
   TI
   LI
   LO
   TS
CP0447712
(S)-N-(5-(4-chlorobenzyl)thiazol-2-yl)-2-(4-chlorophenyl)-3,3-dimethylbutanamide
   Show/Hide
C22H22Cl2N2OS
 1
1
IC50 = 25000 nM
   TI
   LI
   LO
   TS
CP0498695
(S)-2-(4-chlorophenyl)-3-methyl-N-(oxazol-2-yl)butanamide
   Show/Hide
C14H15ClN2O2
 1
1
IC50 = 25000 nM
   TI
   LI
   LO
   TS
CP0491225
(2S)-2-(4-chlorophenyl)-3-methyl-N-(1,2-oxazol-3-yl)butanamide
   Show/Hide
C14H15ClN2O2
 1
1
IC50 = 36000 nM
   TI
   LI
   LO
   TS
CP0513960
(S)-2-cyclopropyl-N-(5-fluorothiazol-2-yl)-2-(pyridin-2-yl)acetamide
   Show/Hide
C13H12FN3OS
 1
1
IC50 = 45000 nM
   TI
   LI
   LO
   TS
CP0502614
(S)-2-(4-chlorophenyl)-N-(thiazol-2-yl)propanamide
   Show/Hide
C12H11ClN2OS
 1
1
IC50 = 46000 nM
   TI
   LI
   LO
   TS
CP0373579
2-(4-chlorophenyl)-3-methyl-N-pyridin-3-ylbutanamide
   Show/Hide
C16H17ClN2O
 1
1
IC50 = 49000 nM
   TI
   LI
   LO
   TS
CP0507704
2-(4-chlorophenyl)-N-(5-fluorothiazol-2-yl)-2-methylpropanamide
   Show/Hide
C13H12ClFN2OS
 1
1
IC50 = 50000 nM
   TI
   LI
   LO
   TS
CP0417863
2-(4-chlorophenyl)-3-methyl-N-pyrimidin-2-ylbutanamide
   Show/Hide
C15H16ClN3O
 1
1
IC50 = 53000 nM
   TI
   LI
   LO
   TS
CP0492774
(S)-2-(4-chlorophenyl)-3-methyl-N-(pyridin-4-yl)butanamide
   Show/Hide
C16H17ClN2O
 1
1
IC50 = 56000 nM
   TI
   LI
   LO
   TS
CP0502891
(S)-2-(4-chlorophenyl)-3-methyl-N-(1,2,3-thiadiazol-5-yl)butanamide
   Show/Hide
C13H14ClN3OS
 1
1
IC50 = 57000 nM
   TI
   LI
   LO
   TS
CP0421850
(S)-2-(2-(4-chlorophenyl)-3-methylbutanamido)thiazole-5-carboxamide
   Show/Hide
C15H16ClN3O2S
 1
1
IC50 = 71000 nM
   TI
   LI
   LO
   TS
CP0510720
(S)-2-(2-(4-chlorophenyl)-3-methylbutanamido)thiazole-5-carboxylic acid
   Show/Hide
C15H15ClN2O3S
 1
1
IC50 = 79000 nM
   TI
   LI
   LO
   TS
CP0463950
(S)-2-(4-chlorophenyl)-N,3-dimethyl-N-(thiazol-2-yl)butanamide
   Show/Hide
C15H17ClN2OS
 1
1
IC50 = 84000 nM
   TI
   LI
   LO
   TS
CP0373563
(S)-N-(1-(4-chlorophenyl)-2-methylpropyl)thiazole-2-carboxamide
   Show/Hide
C14H15ClN2OS
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0373578
(S)-N-tert-butyl-2-(4-chlorophenyl)-3-methylbutanamide
   Show/Hide
C15H22ClNO
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0383862
2,2-bis(4-chlorophenyl)-N-(thiazol-2-yl)acetamide
   Show/Hide
C17H12Cl2N2OS
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0417861
(S)-N-(1-(4-chlorophenyl)-2-methylpropyl)thiazole-2-sulfonamide
   Show/Hide
C13H15ClN2O2S2
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0417862
2-(4-chlorophenyl)-3-methylbutanamide
   Show/Hide
C11H14ClNO
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0421632
2-(4-chlorophenyl)-3-methylbutanoic acid
   Show/Hide
C11H13ClO2
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0421633
(S)-2-(4-chlorophenyl)-3-methyl-N-phenylbutanamide
   Show/Hide
C17H18ClNO
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0426930
2-(4-chlorophenyl)-3-methyl-N-(2H-tetrazol-5-yl)butanamide
   Show/Hide
C12H14ClN5O
 1
1
IC50 = 100000 nM
   TI
   LI
   LO
   TS
CP0426933
2-(4-chlorophenyl)-3-methyl-N-(4-pyridin-3-yl-1,3-thiazol-2-yl)butanamide
   Show/Hide
C19H18ClN3OS
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0426937
1-(4-chlorophenyl)-N-(5-fluorothiazol-2-yl)cyclopropanecarboxamide
   Show/Hide
C13H10ClFN2OS
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0470934
(S)-methyl 2-(4-chlorophenyl)-3-methyl-N-(thiazol-2-yl)butanimidate
   Show/Hide
C15H17ClN2OS
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0470935
(S)-N-(2-(4-chlorophenyl)-3-methylbutyl)thiazol-2-amine
   Show/Hide
C14H17ClN2S
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0491222
1-(4-chlorophenyl)-2-methyl-N-(1,3-thiazol-2-yl)propane-1-sulfonamide
   Show/Hide
C13H15ClN2O2S2
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0491223
(S)-N-benzyl-2-(4-chlorophenyl)-3-methylbutanamide
   Show/Hide
C18H20ClNO
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0510684
(R)-2-(4-chlorophenyl)-3-methyl-N-(thiazol-2-yl)butanamide
   Show/Hide
C14H15ClN2OS
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0514317
2-(4-chlorophenyl)-N-(thiazol-2-yl)acetamide
   Show/Hide
C11H9ClN2OS
 1
1
IC50 = 100000 nM
   TI
   LI
   LO
   TS
CP0514320
(S)-2-cyclopropyl-N-(5-fluorothiazol-2-yl)-2-(4-(methylsulfonyl)phenyl)acetamide
   Show/Hide
C15H15FN2O3S2
 1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0518885
(S)-2-(4-chlorophenyl)-3-methyl-N-(1H-pyrazol-3-yl)butanamide
   Show/Hide
C14H16ClN3O
 1
1
IC50 = 100000 nM
   TI
   LI
   LO
   TS
Clinical Information about the Protein
Target 1 ( Free fatty acid receptor 2 (FFAR2) )
Target Type Clinical trial Target
Disease 1 Target-related Disease  1
1 Abortion [ICD-11: JA00]
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 GLPG0974 Phase 2
Abortion